LDHA and neoplasm: Casagrande demonstrated that platelet activation leads to the release of cytokines, which may contribute to the expansion of ALDH+/CD133+ ovarian CSCs and diminish patients' sensitivity to chemotherapy drugs like paclitaxel, cisplatin and carboplatin, thereby causing chemotherapy resistance and tumor recurrence 86.